cycloplegia: Cycloplegia is paralysis of the ciliary muscle of the eye, resulting in a loss of accommodation.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
557745 |
1. Apply sex-specific ruleNone |
557745 |
2. Check conditionsNone |
557745 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
626 |
4. Check minimum number of eventsNone |
626 |
5. Include endpointsNone |
626 |
6. Filter based on genotype QC (FinnGen only) |
574 |
Control definitions (FinnGen only)
- Control exclude
- G6_CPETAL
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
Similar endpoints
↥List of similar endpoints to
Monoplegia
based on the number of shared cases.
Similar with more cases:
- Cerebral palsy and other paralytic syndromes
- Neurological diseases
- Neurological diseases, wide definition
- Any prescribed medicine buy
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 3782 | 1832 | 1917 |
| Only index persons | 3338 | 1651 | 1687 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.05 | 0.05 | 0.05 |
| Only index persons | 0.06 | 0.06 | 0.06 |
| Median age at first event (years) | |||
| Whole population | 57.60 | 56.77 | 58.25 |
| Only index persons | 56.05 | 55.02 | 57.06 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 574 | 327 | 247 |
| Unadjusted period prevalence (%) | 0.11 | 0.12 | 0.11 |
| Median age at first event (years) | 58.44 | 55.61 | 62.18 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 593
- Matched controls
- 5930
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
G83.1
ICD-10 Finland
Monoplegia of lower limb
+∞
319.7
277
*
G83.2
ICD-10 Finland
Monoplegia of upper limb
+∞
263.9
233
*
G83.3
ICD-10 Finland
Monoplegia, unspecified
+∞
107.7
100
*
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
7.7
68.7
107
165
AA1AD
NOMESCO Finland
CT of head and brain
3.4
46.5
276
1209
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
4.5
46.1
133
357
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
4.5
43.2
122
321
G81.9
ICD-10 Finland
Hemiplegia, unspecified
436.6
41.7
41
*
TAB00
NOMESCO Finland
Lumbar puncture
6.3
41.2
75
134
Z3226
NOMESCO Finland
Physiotherapist
3.5
39.2
177
644
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
4.6
38.4
103
259
R4110
NOMESCO Finland
Physiotherapy
3.1
37.4
244
1101
N03AX16
ATC
[U] pregabalin
3.1
34.3
204
866
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
4.1
33.3
102
283
M03BX01
ATC
baclofen; systemic
9.0
33.0
42
50
XF400
NOMESCO Finland
ECG with 12 standard connections
3.3
32.7
150
545
N03AX12
ATC
[U] gabapentin; oral
3.2
32.3
160
609
R4120
NOMESCO Finland
Occupational therapy
4.6
32.2
85
210
N02AX02
ATC
tramadol; systemic, rectal
2.7
31.8
333
1887
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
5.6
29.7
59
114
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
9.7
29.4
35
38
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
3.5
28.7
113
371
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
3.1
27.8
140
533
N18
ICPC
Paralysis/weakness
10.2
27.0
31
32
Z2446
NOMESCO Finland
Social worker
4.3
26.9
76
197
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
4.5
26.9
71
175
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
6.8
26.8
43
67
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
4.2
26.0
74
193
L28
ICPC
Limited function/disability (L)
2.8
25.3
162
701
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
9.5
24.9
30
33
G57.3
ICD-10 Finland
Lesion of lateral popliteal nerve
9.0
24.7
31
36
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
6.7
24.7
40
63
R56.8
ICD-10 Finland
Other and unspecified convulsions
4.7
23.9
58
133
Z3231
NOMESCO Finland
Registered nurse
2.5
23.5
211
1074
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.7
23.4
156
687
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.8
22.9
139
582
M54.1
ICD-10 Finland
Radiculopathy
5.0
22.1
49
104
R20.2
ICD-10 Finland
Paraesthesia of skin
3.7
21.6
74
220
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.1
21.1
99
358
ZXD35
NOMESCO Finland
Usual procedure
5.4
21.0
43
85
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
2.3
21.0
235
1306
N06AX21
ATC
duloxetine; oral
3.0
20.6
107
410
M54.5
ICD-10 Finland
Low back pain
2.2
20.0
262
1548
M54.4
ICD-10 Finland
Lumbago with sciatica
2.5
19.7
148
685
N28
ICPC
Limited function/disability (N)
8.0
19.7
27
35
N03AE01
ATC
clonazepam; systemic
4.0
19.6
58
155
R51.80
ICD-10 Finland
Headache
2.6
19.2
132
585
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
3.2
19.1
82
281
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
8.0
18.8
26
34
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.9
18.6
97
372
G35
ICD-10 Finland
Multiple sclerosis
8.1
18.4
25
32
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.7
18.2
119
513
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.3
17.9
72
237
R1250
NOMESCO Finland
Evaluation of functional capability
5.7
17.8
34
63
G82.2
ICD-10 Finland
Paraplegia, unspecified
+∞
17.8
17
*
Z2221
NOMESCO Finland
Medical doctor
2.2
17.3
193
1055
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
3.1
15.9
72
254
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
5.0
15.6
34
71
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
3.7
15.5
52
152
J01MA02
ATC
ciprofloxacin; systemic
2.0
15.4
259
1640
R26.8
ICD-10 Finland
Other and unspecified abnormalities of gait and mobility
5.7
15.4
29
53
ZXD05
NOMESCO Finland
Urgent procedure
2.1
15.3
203
1177
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.6
15.3
99
423
TPH04
NOMESCO Finland
Cathetrisation of vein
2.2
15.0
159
844
WX892
NOMESCO Finland
Monitored bed care
3.1
14.9
67
235
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
14.8
316
2167
N02AA05
ATC
oxycodone; systemic
2.3
14.7
142
725
A28
ICPC
Limited function/disability NOS
2.3
14.6
137
691
M79.6
ICD-10 Finland
Pain in limb
2.0
14.6
295
1981
PA6AD
NOMESCO Finland
CT of neck arteries
3.9
14.4
44
120
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.3
14.4
125
610
M79.2
ICD-10 Finland
Neuralgia and neuritis, unspecified
5.9
14.3
26
46
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.5
14.0
100
447
XA800
NOMESCO Finland
Neuropsychological investigation
4.0
13.9
41
109
L17
ICPC
Foot/toe symptom/complaint
2.0
13.9
214
1302
M48.0
ICD-10 Finland
Spinal stenosis
2.4
13.6
101
459
WX408
NOMESCO Finland
General anesthesy, balanced
2.1
13.5
173
983
T36
ICD-10 Finland
Poisoning by systemic antibiotics
3.9
13.4
41
112
R42
ICD-10 Finland
Dizziness and giddiness
2.1
13.2
163
914
NA1AD
NOMESCO Finland
Cervical spine CT examination
3.4
13.2
49
153
A01
ICPC
Pain general/multiple sites
2.6
13.1
86
368
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
2.2
13.1
131
677
N02BF01
ATC
gabapentin; oral
2.6
13.0
85
363
IAA01
NOMESCO Finland
Assessment of need for psychiatric treatment
4.5
13.0
32
74
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
6.3
13.0
22
36
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.0
12.9
178
1037
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.7
12.9
75
303
Z2445
NOMESCO Finland
Psychologist
4.0
12.5
36
94
ZXE10
NOMESCO Finland
More than one and less than three hours
1.9
12.5
229
1468
ZXE20
NOMESCO Finland
More than three and less than five hours
2.4
12.5
100
470
ZXD10
NOMESCO Finland
Scheduled procedure
1.9
12.3
238
1550
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
4.0
12.3
35
91
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
3.3
12.2
47
150
B01AB05
ATC
enoxaparin; parenteral
1.9
12.2
210
1317
N06AX16
ATC
venlafaxine; oral
2.3
12.2
104
502
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
5.2
12.0
25
50
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.9
12.0
235
1536
M03BC01
ATC
orphenadrine (citrate); systemic
2.0
11.9
156
889
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.3
11.9
98
466
L86
ICPC
Back syndrome with radiating pain
3.0
11.8
55
197
G83.9
ICD-10 Finland
Paralytic syndrome, unspecified
66.3
11.6
13
*
X59
ICD-10 Finland
Exposure to unspecified factor
2.1
11.6
132
714
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.2
11.5
114
585
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.1
11.4
131
710
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.9
11.4
190
1175
XKD06
NOMESCO Finland
Physiologic investigation of micturition
4.0
11.3
33
87
M47.9
ICD-10 Finland
Spondylosis, unspecified
4.1
11.3
31
78
M54.9
ICD-10 Finland
Dorsalgia, unspecified
2.3
11.3
92
434
N06AX11
ATC
mirtazapine; oral
1.9
11.2
224
1464
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
2.5
11.2
73
311
JN3AD
NOMESCO Finland
Abdominal CT examination
2.3
11.2
95
457
R52.9
ICD-10 Finland
Pain, unspecified
2.4
11.1
82
370
U08
ICPC
Urinary retention
5.4
11.1
22
42
SPAT1229
SPAT
Assessment of need for aid
2.8
11.1
57
215
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
3.3
11.1
43
138
WW200
NOMESCO Finland
Immunization
4.6
11.1
26
58
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.5
11.0
72
307
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
3.0
11.0
50
176
W00
ICD-10 Finland
Fall on same level involving ice and snow
2.4
11.0
84
385
NG4AA
NOMESCO Finland
Lower leg X-ray examination
3.8
10.8
33
90
H53.1
ICD-10 Finland
Subjective visual disturbances
2.8
10.8
56
213
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.8
10.6
275
1936
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.0
10.6
136
767
Z01.8
ICD-10 Finland
Other specified special examinations
2.0
10.6
148
860
G82.1
ICD-10 Finland
Spastic paraplegia
+∞
10.4
10
*
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
3.9
10.3
30
79
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
3.9
10.3
30
79
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
3.1
10.3
45
155
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
3.6
10.2
34
99
RS220, ,
NOMESCO Finland
11.6
10.1
18
16
N29
ICPC
Neurological sympt/complt other
5.1
10.1
21
42
A04
ICPC
Weakness/tiredness general
2.1
10.1
109
576
N05BA01
ATC
diazepam; systemic, rectal
2.2
10.1
94
469
H53.2
ICD-10 Finland
Diplopia
3.7
10.1
32
90
ZX120
NOMESCO Finland
Intravenous
2.4
10.1
71
314
W10
ICD-10 Finland
Fall on and from stairs and steps
3.0
10.0
46
163
N03AX11
ATC
topiramate; oral
4.3
10.0
26
63
W19
ICD-10 Finland
Unspecified fall
2.4
10.0
74
335
N86
ICPC
Multiple sclerosis
17.1
9.9
15
9
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.2
9.9
91
451
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.5
9.9
68
297
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
2.5
9.9
65
278
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
3.2
9.9
40
132
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.8
9.8
50
188
C03CA01
ATC
furosemide; systemic
1.8
9.8
196
1273
H02AB06
ATC
prednisolone; systemic
1.7
9.7
296
2165
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
2.6
9.7
61
255
N06AA09
ATC
amitriptyline; systemic
2.5
9.7
67
293
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.8
9.7
51
195
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.3
9.6
80
380
R50.9
ICD-10 Finland
Fever, unspecified
2.1
9.6
107
571
G44.2
ICD-10 Finland
Tension-type headache
2.1
9.6
98
507
R5110, ,
SPAT
2.4
9.5
68
302
IGY01
NOMESCO Finland
Accelerated psychiatric treatment contact
4.3
9.5
24
57
S93.4
ICD-10 Finland
Sprain and strain of ankle
2.3
9.4
75
350
G83.8
ICD-10 Finland
Other specified paralytic syndromes
+∞
9.4
9
*
G43.3
ICD-10 Finland
Complicated migraine
5.0
9.4
20
41
Z50.1
ICD-10 Finland
Other physical therapy
3.0
9.3
43
153
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.3
9.3
77
365
A46
ICD-10 Finland
Erysipelas
2.1
9.3
99
519
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.3
9.3
73
339
D10
ICPC
Vomiting
2.9
9.2
44
160
L03
ICPC
Low back symptom/complaint
1.8
9.2
183
1183
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.6
9.2
53
213
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
3.0
9.2
40
138
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.1
9.1
90
459
ZXE00
NOMESCO Finland
One hour or less
1.7
9.0
231
1602
R06.0
ICD-10 Finland
Dyspnoea
1.8
8.9
179
1158
UJF92
NOMESCO Finland
Capsular endoscopy
5.0
8.9
19
39
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
3.4
8.9
32
98
N17
ICPC
Vertigo/dizziness
2.1
8.8
91
471
R07.4
ICD-10 Finland
Chest pain, unspecified
1.8
8.8
180
1171
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.8
8.8
45
170
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
3.6
8.7
29
84
M03BX02
ATC
tizanidine; oral
1.7
8.6
364
2872
X58
ICD-10 Finland
Exposure to other specified factors
2.0
8.6
100
542
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.5
8.6
56
239
Z71.8
ICD-10 Finland
Other specified counselling
1.7
8.5
215
1480
AA1BD
NOMESCO Finland
Extensive CT of head and brain
4.3
8.5
22
53
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
2.5
8.5
53
221
J45.9
ICD-10 Finland
Asthma, unspecified
1.9
8.5
126
741
N05AH04
ATC
quetiapine; oral
1.9
8.5
117
672
G56.2
ICD-10 Finland
Lesion of ulnar nerve
3.4
8.5
31
96
M54.2
ICD-10 Finland
Cervicalgia
2.3
8.3
63
287
X57
ICD-10 Finland
Unspecified privation
3.8
8.3
25
68
R60.0
ICD-10 Finland
Localized oedema
2.1
8.2
88
462
B01AC04
ATC
clopidogrel; oral
1.9
8.1
109
619
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
2.7
8.1
43
165
J46
ICD-10 Finland
Status asthmaticus
4.1
8.1
22
55
G43.9
ICD-10 Finland
Migraine, unspecified
2.7
8.1
45
177
S06.0
ICD-10 Finland
Concussion
2.1
8.1
78
393
N02AJ06
ATC
codeine and paracetamol; systemic
1.6
8.0
263
1932
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
2.2
8.0
70
340
NH1AD
NOMESCO Finland
Ankle and foot CT
4.7
7.9
18
39
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
7.9
7.9
17
22
PA6AG
NOMESCO Finland
Limited MRI examination of neck vasculature with high intensity magnet
13.3
7.9
13
10
G37.9
ICD-10 Finland
Demyelinating disease of central nervous system, unspecified
13.3
7.9
13
10
WYA30
NOMESCO Finland
Treatment of a patient needing special arrangements
2.4
7.9
56
248
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.4
7.9
55
242
K90
ICPC
Stroke/cerebrovascular accident
3.9
7.9
23
61
ZY010
NOMESCO Finland
Hospital outpatient
2.9
7.9
38
139
N99
ICPC
Neurological disease other
8.6
7.9
16
19
ZXA00
NOMESCO Finland
Right side
1.7
7.8
161
1043
R4130
NOMESCO Finland
Speech therapy
3.7
7.8
24
66
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
2.0
7.8
86
457
N04BA02
ATC
levodopa and decarboxylase inhibitor; oral
3.4
7.7
27
81
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
2.7
7.7
42
164
G62.9
ICD-10 Finland
Polyneuropathy, unspecified
3.3
7.6
29
92
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
3.0
7.6
34
119
NH1BG
NOMESCO Finland
Ankle and foot MRI examination with high intensity magnet
4.2
7.6
20
49
JN4BD
NOMESCO Finland
Extensive body CT
2.2
7.5
69
341
L29
ICPC
Musculoskeletal sympt/complt other
2.3
7.5
61
287
D18
ICPC
Change in faeces/bowel movements
3.6
7.5
24
68
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.8
7.5
37
137
NF3AA
NOMESCO Finland
Femur X-ray examination
4.0
7.5
21
54
B01AF02
ATC
apixaban; oral
2.0
7.5
87
470
ABB00
NOMESCO Finland
Excision of lesion of spinal canal
81.1
7.4
8
*
D32.1
ICD-10 Finland
Benign neoplasm: Spinal meninges
81.1
7.4
8
*
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
1.6
7.4
318
2480
R40.2
ICD-10 Finland
Coma, unspecified
8.5
7.4
15
18
IEY01
NOMESCO Finland
Psychoeducation, individual
11.0
7.3
13
12
EB1AA, ,
SPAT
2.5
7.3
47
199
JN4AD
NOMESCO Finland
Body CT examination
2.1
7.3
76
395
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.8
7.3
35
128
J01MA12
ATC
levofloxacin; systemic
1.8
7.2
113
673
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.2
7.2
59
278
NH1BA
NOMESCO Finland
Ankle extensive X-ray examination
4.0
7.2
20
51
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
4.0
7.2
20
51
S29
ICPC
Skin symptom/complaint other
1.8
7.2
132
826
B01AB04
ATC
dalteparin; parenteral
2.9
7.2
34
123
N05CF01
ATC
zopiclone; oral
1.6
7.2
196
1366
R4190
NOMESCO Finland
Nutritional therapy
3.0
7.2
32
112
N02BF02
ATC
pregabalin; oral
2.5
7.2
47
201
P03
ICPC
Feeling depressed
2.2
7.2
65
320
F43.29
ICD-10 Finland
Adaptation disorder UNS
3.9
7.1
21
56
RS221, ,
NOMESCO Finland
6.2
7.1
18
30
L04AX01
ATC
azathioprine; systemic
3.0
7.1
31
107
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
12.2
7.1
12
10
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.4
7.1
50
221
WX110, ,
SPAT
2.6
7.1
42
171
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
2.4
7.0
50
222
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
4.5
7.0
17
39
N05AH03
ATC
olanzapine; systemic
2.4
7.0
46
197
NK6QA
NOMESCO Finland
Measurement of bone density from two or more locations with X-ray
2.4
6.9
49
217
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
2.6
6.9
39
155
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.3
6.9
54
250
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.9
6.9
31
109
N05AA02
ATC
levomepromazine; systemic
2.9
6.9
31
109
WZC00
NOMESCO Finland
Treatment plan or consultation
1.6
6.8
215
1548
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.5
6.8
41
168
R55
ICD-10 Finland
Syncope and collapse
2.0
6.8
76
404
R02
ICPC
Shortness of breath/dyspnoea
1.9
6.8
88
493
T91.3
ICD-10 Finland
Sequelae of injury of spinal cord
40.5
6.8
8
*
R10.0
ICD-10 Finland
Acute abdomen
3.4
6.8
24
73
R05
ICPC
Cough
1.7
6.8
152
1005
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.0
6.7
75
399
ZYC01
NOMESCO Finland
Remote contact by phone
2.4
6.7
45
195
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.8
6.6
101
596
UJF32
NOMESCO Finland
Coloscopy
1.7
6.6
153
1018
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
3.3
6.6
24
74
R03DC03
ATC
montelukast; oral
1.8
6.6
100
589
ICB03
NOMESCO Finland
Psychiatric treatment plan, monitoring
4.2
6.6
17
41
WX402
NOMESCO Finland
General anaesthesia
1.7
6.5
131
839
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
2.5
6.5
40
166
U07
ICPC
Urine symptom/complaint other
2.2
6.5
58
284
WX110
NOMESCO Finland
Infiltration anesthesia
1.6
6.5
414
3496
U05
ICPC
Urination problems other
2.5
6.4
41
173
G95.1
ICD-10 Finland
Vascular myelopathies
70.6
6.4
7
*
F44.4
ICD-10 Finland
Dissociative motor disorders
70.6
6.4
7
*
W17
ICD-10 Finland
Other fall from one level to another
2.9
6.4
30
108
ZXA05
NOMESCO Finland
Left side
1.7
6.4
143
943
M89.0
ICD-10 Finland
Algoneurodystrophy
8.3
6.4
13
16
UJF30
NOMESCO Finland
Ileoscopy through colon
2.1
6.4
64
328
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.1
6.4
62
314
M54.3
ICD-10 Finland
Sciatica
2.4
6.3
42
181
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
2.0
6.3
65
336
G83.4
ICD-10 Finland
Cauda equina syndrome
+∞
6.3
6
*
AWB00
NOMESCO Finland
Reoperation for superficial infection in surgery of the nervous system
+∞
6.3
6
*
NF1AA
NOMESCO Finland
Hip X-ray examination
2.1
6.2
61
309
S63.5
ICD-10 Finland
Sprain and strain of wrist
3.0
6.2
27
93
TPH07
NOMESCO Finland
Cathetrisation of artery
2.0
6.2
71
381
G54.0
ICD-10 Finland
Brachial plexus disorders
3.3
6.2
23
72
P99
ICPC
Psychological disorders other
3.3
6.2
23
72
109
Kela drug reimbursment
Multiple sclerosis
6.4
6.2
15
24
A02BC02
ATC
pantoprazole; systemic
1.6
6.2
397
3336
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.2
6.1
24
78
C07AB07
ATC
bisoprolol; oral
1.5
6.1
284
2222
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.4
6.1
41
178
N05BA06
ATC
lorazepam; systemic, sublingual
2.4
6.0
40
172
S82.3
ICD-10 Finland
Fracture of lower end of tibia
3.9
6.0
17
44
D01
ICPC
Abdominal pain/cramps general
1.9
6.0
78
437
N02BE01
ATC
paracetamol; systemic, rectal
1.9
6.0
525
4753
H02AB07
ATC
prednisone; oral
1.9
6.0
83
475
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.6
6.0
146
982
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
48
56
9.24
38.38
1.1
1.1
—
—
—
0
0
311
1629
2.91
35.89
3.2
2.1
187.36
225.47
u/l
0.29
304
1554
45
53
9.11
35.68
1.1
1.1
—
—
—
0
0
36
32
11.91
34.76
1.1
1.0
—
—
—
0
0
266
1302
2.89
34.54
6.9
4.0
91.11
90.26
%
0.21
261
1275
42
48
9.34
34.05
1.1
1.1
—
—
—
0
0
108
343
3.63
28.83
2.5
2.5
24.83
16.64
au/ml
—
6
25
187
828
2.84
28.37
6.4
2.1
29.46
29.42
s
0.02
182
805
30
28
11.23
27.98
1.1
1.0
1.92
1.11
u/l
—
10
14
377
2382
2.60
27.21
7.5
6.3
1.21
1.21
mmol/l
0.98
356
2200
30
33
9.52
24.92
1.3
1.1
0.61
0.49
ratio
0.96
16
19
56
124
4.88
24.11
1.3
1.3
5.51
16.61
e6/l
0.75
39
94
56
126
4.80
23.65
1.4
1.4
263.40
104.85
e6/l
0.32
40
99
390
2648
2.38
21.88
8.4
7.1
1.21
1.21
mmol/l
0.07
353
2288
184
917
2.46
21.06
4.5
2.8
1.12
1.02
e6/l
0.12
90
482
173
853
2.45
20.15
4.7
2.9
3.74
2.26
e6/l
0.96
74
413
230
1284
2.29
20.15
3.2
2.3
—
—
—
0
0
143
676
2.47
18.04
2.1
1.8
—
—
—
0
0
344
2326
2.14
17.97
6.1
4.9
34.86
35.80
g/l
2.20
329
2194
132
603
2.53
17.90
6.2
7.7
0.20
1.03
mmol/l
1.46
112
505
413
3003
2.24
17.83
14.5
10.0
4.37
4.11
e9/l
1.35
362
2634
174
903
2.31
17.74
2.3
1.9
—
—
—
0
0
85
311
3.02
17.66
2.0
1.6
—
—
—
0
0
250
1504
2.14
17.66
5.0
3.1
0.51
0.49
e6/l
0.03
189
1113
389
2780
2.16
17.30
7.5
6.7
10.34
11.53
umol/l
1.59
372
2650
350
2454
2.04
15.73
16.9
13.7
1.21
1.24
inr
0.61
291
2045
145
744
2.26
14.88
6.5
6.6
104.46
104.08
mmol/l
0.38
145
744
268
1733
2.00
14.88
5.2
3.3
33.78
100.24
e6/l
1.03
212
1337
99
435
2.53
14.37
2.4
3.4
67.29
66.94
g/l
0.17
93
404
162
884
2.15
14.19
6.7
3.5
0.81
0.82
mmol/l
0.51
150
840
293
1981
1.95
14.04
6.7
3.9
349.30
115.38
e6/l
0.62
221
1404
127
638
2.26
13.61
2.2
1.9
—
—
—
0
0
330
2344
1.92
13.42
2.5
2.1
90.91
95.97
pmol/l
1.32
192
1240
97
443
2.42
12.90
3.6
2.8
10.15
10.68
g/l
0.61
88
410
173
1003
2.02
12.70
6.8
3.8
285.40
312.96
ng/l
0.05
137
770
62
230
2.89
12.48
1.8
2.3
40.43
39.62
u/l
0.12
56
204
62
236
2.82
11.90
2.6
2.1
8.01
8.46
iu/ml
0.02
13
57
45
144
3.30
11.64
3.2
3.0
0.92
1.99
index
1.06
25
82
86
394
2.38
11.30
1.8
1.6
—
—
—
0
0
44
142
3.27
11.23
2.1
2.9
0.00
0.00
g/l
-0.00
44
134
47
161
3.08
10.87
2.1
2.7
0.07
0.03
g/l
0.19
47
146
217
1417
1.84
10.84
2.7
2.2
2.69
2.94
mg/l
0.92
191
1231
23
29
8.21
10.68
1.3
1.1
—
—
—
0
0
21
23
9.42
10.58
1.5
1.2
—
—
—
0
0
98
488
2.21
10.57
3.1
2.4
33.36
36.31
u/l
0.28
89
411
153
905
1.93
10.33
1.8
1.7
1067.81
1212.84
nmol/l
1.26
116
691
128
712
2.02
10.31
8.5
5.3
1.03
1.03
mmol/l
0.05
117
659
467
3872
1.97
10.31
5.9
4.4
14.21
12.03
mm/h
2.04
445
3606
330
2471
1.76
10.14
3.6
2.7
—
—
estimate
—
0
0
49
181
2.86
9.93
2.3
2.8
1.23
1.08
g/l
0.07
49
160
103
536
2.12
9.91
4.8
3.4
1.82
2.02
mmol/l
0.21
94
449
51
194
2.78
9.79
2.2
2.6
2.93
3.01
g/l
0.31
51
178
472
3959
1.94
9.63
11.3
8.4
79.64
78.86
u/l
0.18
460
3742
53
208
2.70
9.59
2.2
2.5
3.73
3.78
g/l
0.09
53
192
53
208
2.70
9.59
2.2
2.5
7.46
7.54
g/l
0.12
53
192
53
208
2.70
9.59
2.2
2.5
4.21
4.27
g/l
0.20
53
192
113
617
2.03
9.53
7.6
4.5
251.49
247.66
u/l
0.09
106
590
44
157
2.95
9.49
2.1
2.7
0.00
0.00
g/l
-0.00
44
135
187
1210
1.80
9.38
3.4
2.7
7.44
5.10
e6/l
1.34
174
1101
25
62
4.17
9.33
1.2
1.2
—
—
—
0
0
42
155
2.84
8.54
1.2
1.3
—
—
—
0
0
251
1804
1.68
8.45
4.1
3.3
7.35
7.55
mmol/l
0.26
218
1522
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
39
139
2.93
8.44
24.3
3.1
0.32
0.38
iu/ml
0.37
18
79
21
50
4.32
8.26
1.1
1.2
—
—
—
0
0
25
68
3.79
8.25
1.4
1.1
—
—
—
0
0
277
2052
1.66
8.24
5.0
3.9
44.24
64.49
ng/l
0.31
207
1495
21
51
4.23
8.06
1.1
1.2
—
—
—
0
0
22
56
4.04
7.95
1.1
1.1
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
19
29
6.73
7.94
1.4
1.2
—
—
—
0
0
21
52
4.15
7.86
1.1
1.2
—
—
—
0
0
21
52
4.15
7.86
1.1
1.2
—
—
—
0
0
308
2362
1.63
7.85
3.1
2.5
74.44
77.32
nmol/l
0.85
288
2116
28
86
3.37
7.75
1.3
1.2
2.78
2.43
u/ml
—
9
28
356
2848
1.63
7.50
5.2
4.0
0.00
0.55
estimate
0.52
51
562
353
2822
1.62
7.43
5.1
4.0
0.02
5.82
estimate
0.80
58
602
37
138
2.79
7.39
1.2
1.2
—
—
—
0
0
176
1189
1.68
7.28
3.6
1.8
1.35
1.25
mg/l
0.16
139
948
349
2797
1.60
7.14
5.1
4.0
0.00
0.00
estimate
-0.00
54
589
248
1841
1.60
6.97
3.7
3.4
2.37
2.35
mmol/l
0.55
227
1683
42
173
2.54
6.93
1.5
1.2
—
—
—
0
0
194
1364
1.63
6.79
3.4
2.8
340.17
345.50
umol/l
0.31
173
1202
229
1681
1.59
6.68
3.6
2.5
53.46
111.02
u/l
0.65
212
1567
103
611
1.83
6.67
2.0
1.8
1.52
1.48
%
0.25
94
524
40
166
2.51
6.51
1.3
1.3
3.42
11.70
u/ml
—
5
28
10
7
14.50
6.41
1.3
1.1
—
—
—
0
0
131
846
1.70
6.31
2.6
2.4
2.41
2.31
g/l
1.20
125
780
99
595
1.80
6.12
2.8
3.0
6.50
7.90
umol/l
0.46
82
523
231
1728
1.55
6.07
4.3
4.1
6.85
9.46
mg/mmol
0.70
157
1084
17
33
5.27
6.05
1.4
1.1
—
—
—
0
0
17
34
5.12
5.91
1.2
1.1
—
—
—
0
0
69
376
1.95
5.78
5.7
3.2
229.43
204.79
ng/l
0.13
60
346
145
984
1.63
5.73
1.4
1.3
17.06
36.80
iu/ml
4.53
47
309
12
16
7.63
5.65
1.4
1.2
—
—
—
0
0
12
16
7.63
5.65
1.3
1.1
—
—
—
0
0
12
16
7.63
5.65
1.3
1.1
—
—
—
0
0
27
99
2.81
5.60
1.5
1.3
154.00
158.36
au/ml
0.06
12
29
12
17
7.18
5.46
1.4
1.2
—
—
—
0
0
120
786
1.66
5.43
2.7
2.4
20.68
22.79
%
1.14
113
735
59
317
1.96
5.16
5.7
3.7
1.13
1.91
mmol/l
1.23
44
231
27
104
2.67
5.13
2.4
1.5
—
—
—
0
0
218
1662
1.49
5.03
5.0
3.3
1149.74
1333.45
ng/l
0.42
206
1420
45
223
2.10
4.90
1.2
1.2
0.20
2.20
u/ml
—
6
13
23
84
2.81
4.83
4.1
3.5
—
3298.38
—
0
8
63
354
1.87
4.83
3.3
2.9
132.73
128.66
g/l
0.73
63
346
24
90
2.74
4.80
1.3
1.2
3.11
3.52
u/ml
—
9
40
14
30
4.75
4.70
1.8
1.9
—
—
—
0
0
57
313
1.91
4.68
2.7
2.6
1.43
1.19
%
0.97
57
313
229
1785
1.46
4.64
4.7
3.4
32.06
33.64
u/l
0.31
219
1685
7
5
14.14
4.58
1.3
1.4
—
—
—
0
0
14
31
4.60
4.58
1.5
1.8
—
—
—
0
0
539
5001
1.85
4.57
30.6
15.9
26.14
23.30
mg/l
1.26
492
4126
149
1068
1.53
4.55
3.0
3.0
2.47
2.45
mmol/l
0.77
131
968
130
907
1.55
4.48
1.4
1.3
10.16
15.40
u/ml
0.61
45
350
10
16
6.34
4.31
1.5
1.1
—
—
—
0
0
168
1250
1.48
4.25
1.5
1.3
1.14
1.62
u/ml
0.48
39
334
25
104
2.47
4.11
1.6
1.3
—
—
—
0
0
25
104
2.47
4.11
1.6
1.3
—
—
—
0
0
15
47
3.25
4.08
1.7
1.4
28978.57
24651.59
e6/l
—
7
22
21
81
2.65
4.01
1.0
1.1
—
—
—
0
0
9
14
6.51
3.99
1.4
1.3
—
—
—
0
0
52
294
1.84
3.93
1.8
1.5
—
—
—
0
0
204
1597
1.42
3.90
2.1
1.7
18.85
20.79
nmol/l
1.29
180
1343
7
8
8.84
3.78
1.7
1.4
—
—
—
0
0
7
8
8.84
3.78
1.7
1.4
—
—
—
0
0
7
8
8.84
3.78
1.7
1.5
—
—
—
0
0
443
3975
1.45
3.78
4.7
4.4
14.88
14.81
pmol/l
0.26
418
3634
30
141
2.19
3.77
1.3
1.3
—
—
—
0
0
35
176
2.05
3.72
1.4
1.5
0.01
0.04
iu/ml
—
7
33
11
25
4.46
3.64
3.3
2.8
2028.27
784.16
u/ml
0.35
11
25
100
691
1.54
3.56
2.5
2.4
153.06
125.54
ug/g
0.21
80
545
44
244
1.87
3.55
1.8
1.9
1.47
1.56
g/l
0.25
37
222
68
433
1.64
3.42
2.9
2.5
6.53
7.18
ug/l
0.11
54
391
81
539
1.58
3.41
2.3
2.1
372.30
380.37
nmol/l
0.13
73
506
15
53
2.88
3.38
1.7
1.4
1233.67
1547.24
e6/l
—
9
33
36
191
1.94
3.32
2.4
1.7
—
—
—
0
0
28
529
0.51
3.19
2.3
1.9
3.08
3.48
ratio
1.12
22
426
37
202
1.89
3.15
2.2
1.8
—
—
—
0
0
35
188
1.92
3.13
3.2
3.1
—
—
—
0
0
65
419
1.62
3.12
3.2
2.7
68.73
66.34
ml/min/173m2
0.17
26
190
295
2530
1.33
2.98
3.8
3.0
108.94
125.99
ug/l
0.60
271
2359
63
409
1.60
2.95
3.5
3.6
76.46
78.12
ng/l
0.05
54
356
11
32
3.48
2.91
1.4
1.4
—
—
—
0
0
29
152
1.95
2.80
1.3
1.2
16.12
9.88
u/l
0.94
19
122
64
423
1.58
2.79
1.8
1.5
—
—
—
0
0
9
23
3.96
2.78
1.0
1.0
1746.67
1562.87
miu/ml
—
9
23
7
14
5.05
2.73
1.3
1.2
—
—
—
0
0
18
79
2.32
2.70
1.2
1.4
0.53
23.91
nmol/l
0.50
18
73
511
4801
1.47
2.65
26.3
15.4
84.31
80.89
ml/min/173m2
2.84
489
4445
10
30
3.37
2.61
1.3
1.1
—
—
—
0
0
48
304
1.63
2.50
2.5
3.7
4.44
4.53
pmol/l
0.25
42
266
13
51
2.58
2.46
2.5
1.7
—
—
—
0
0
351
3135
1.29
2.43
3.5
3.0
—
—
—
0
0
36
213
1.73
2.42
1.6
1.3
39.17
23.49
iu/l
1.40
26
186
500
4698
1.41
2.41
6.4
5.4
1.83
1.92
mu/l
0.66
476
4331
13
52
2.53
2.37
3.3
2.4
—
—
—
0
0
17
78
2.21
2.33
1.6
1.5
0.39
0.39
nmol/l
0.01
12
60
38
233
1.67
2.26
2.1
1.5
0.38
0.34
mg/l
0.12
16
100
31
180
1.76
2.23
2.2
2.0
1375.75
6957.84
u/l
—
10
78
21
107
2.00
2.23
1.5
1.3
279.57
245.54
u/ml
0.17
14
57
5
9
5.59
2.21
1.6
1.4
—
—
—
0
0
13
54
2.44
2.21
2.3
2.0
—
—
—
0
0
12
48
2.53
2.19
3.1
3.2
17.00
12.91
index
—
7
32
8
24
3.36
2.18
1.3
1.3
—
—
—
0
0
29
168
1.76
2.11
2.9
4.4
1.84
3.00
ratio
0.92
15
100
6
15
4.03
2.04
1.0
1.0
—
—
—
0
0
7
21
3.36
1.97
2.0
1.3
—
—
—
0
0
376
3437
1.26
1.93
4.7
3.4
52.45
49.10
u/l
0.35
358
3251
15
72
2.11
1.87
1.0
1.2
—
—
—
0
0
13
59
2.23
1.85
4.0
3.9
—
—
—
0
0
6
17
3.55
1.84
1.8
1.9
0.67
0.60
mmol/l
—
6
17
29
177
1.67
1.79
1.5
1.6
—
—
—
0
0
6
18
3.36
1.75
1.2
2.0
—
—
—
0
0
6
18
3.36
1.75
1.2
2.0
—
—
—
0
0
9
36
2.52
1.74
23.6
14.1
780.67
834.92
nmol/l
—
9
36
25
148
1.72
1.73
2.8
1.6
—
—
—
0
0
13
61
2.16
1.72
2.3
1.9
—
—
—
0
0
22
126
1.77
1.70
1.8
1.5
—
—
—
0
0
444
4164
1.26
1.70
39.1
20.7
330.77
332.14
g/l
2.58
444
4144
51
361
1.45
1.68
1.2
1.3
69.19
128.46
u/ml
0.74
15
140
27
165
1.67
1.67
1.2
1.3
—
—
—
0
0
6
19
3.18
1.66
1.2
1.9
—
—
—
0
0
24
387
0.60
1.65
1.3
1.7
2.96
3.50
mmol/l
1.10
18
289
133
1098
1.27
1.63
1.8
1.8
58772321.20
19037636.65
pmol/l
0.29
114
914
27
167
1.65
1.61
1.2
1.4
340.77
290.33
ug/g
0.81
17
94
7
26
2.71
1.58
1.1
1.8
—
—
—
0
0
7
26
2.71
1.58
1.1
1.8
—
—
—
0
0
7
26
2.71
1.58
1.1
1.8
—
—
—
0
0
7
26
2.71
1.58
1.1
1.8
—
—
—
0
0
27
168
1.64
1.58
1.1
1.2
—
—
—
0
0
7
28
2.52
1.45
1.3
1.8
66.43
118.51
ng/l
—
7
28
6
22
2.74
1.43
1.0
1.0
—
—
—
0
0
23
141
1.66
1.43
1.7
2.0
2.75
4.46
iu/l
—
6
51
42
298
1.44
1.40
6.7
3.8
55.05
49.98
%
0.64
42
293
22
135
1.65
1.37
2.1
1.5
5893.67
11555.69
e6/l
0.57
15
104
26
168
1.57
1.34
1.1
1.2
—
—
—
0
0
12
61
1.99
1.33
1.5
2.9
26.67
20.48
mg/l
—
6
30
12
61
1.99
1.33
1.5
1.2
—
—
—
0
0
503
4828
1.28
1.33
5.8
5.2
6.07
5.96
mmol/l
1.07
477
4436
8
34
2.37
1.29
1.9
1.2
—
—
—
0
0
8
34
2.37
1.29
1.9
1.2
—
—
—
0
0
76
607
1.29
1.23
9.7
7.5
—
—
—
0
0
22
140
1.59
1.22
2.0
1.7
—
—
—
0
0
5
19
2.64
1.22
1.2
1.2
—
—
—
0
0
18
110
1.66
1.16
1.4
1.6
—
—
—
0
0
5
114
0.43
1.13
1.4
1.6
—
—
—
0
0
7
31
2.27
1.10
1.0
1.1
—
—
—
0
0
37
270
1.40
1.09
1.0
1.0
—
—
—
0
0
8
41
1.96
1.09
1.4
1.8
—
—
—
0
0
491
4727
1.23
1.08
7.6
6.5
40.05
39.32
mmol/mol
0.98
469
4436
7
32
2.20
1.08
3.4
3.3
0.57
0.91
index
—
7
32
68
548
1.27
1.04
3.8
3.2
—
—
—
0
0
145
1270
1.19
1.01
5.6
4.1
1.01
1.02
kg/l
0.48
106
856
7
135
0.51
0.99
1.3
1.5
—
—
—
0
0
5
23
2.18
0.98
1.0
1.0
—
—
—
0
0
0
30
0.00
0.97
0.0
1.3
—
9.87
—
0
30
7
37
1.90
0.94
1.7
1.4
—
—
—
0
0
6
27
2.23
0.93
2.7
2.0
—
—
—
0
0
9
52
1.74
0.92
1.1
1.3
—
—
—
0
0
6
28
2.15
0.91
3.2
4.0
95.83
142.57
nmol/l
—
6
28
6
28
2.15
0.91
1.5
1.8
—
—
—
0
0
6
28
2.15
0.91
1.5
1.8
—
—
—
0
0
12
71
1.70
0.89
1.2
1.3
—
—
—
0
0
12
71
1.70
0.89
1.2
1.3
—
—
—
0
0
10
56
1.80
0.88
2.3
3.7
2.39
3.93
nmol/l
—
10
56
19
128
1.50
0.87
1.8
1.5
—
—
—
0
0
12
72
1.68
0.85
1.3
1.3
—
—
—
0
0
12
72
1.68
0.85
1.2
1.3
—
—
—
0
0
537
5248
1.25
0.82
18.7
12.3
26.39
25.98
u/l
0.22
530
5108
14
89
1.59
0.82
1.6
1.6
—
—
—
0
0
8
47
1.71
0.81
1.1
1.7
—
—
—
0
0
8
47
1.71
0.81
1.1
1.7
—
—
—
0
0
8
47
1.71
0.81
1.1
1.7
—
—
—
0
0
0
24
0.00
0.79
0.0
2.0
—
0.86
—
0
5
21
148
1.43
0.79
2.2
1.7
—
—
—
0
0
12
74
1.63
0.78
1.3
1.3
—
—
—
0
0
12
74
1.63
0.78
1.3
1.3
—
—
—
0
0
66
551
1.22
0.78
3.4
4.4
4.22
26.94
ug/l
0.94
53
461
232
2150
1.13
0.74
5.0
3.9
0.05
0.03
estimate
0.17
44
497
9
55
1.65
0.73
1.1
1.1
—
—
—
0
0
15
100
1.51
0.73
2.5
3.2
0.70
0.78
nmol/l
—
10
82
12
76
1.59
0.72
1.4
1.5
—
—
—
0
0
108
952
1.16
0.71
1.9
1.6
—
—
—
0
0
9
145
0.61
0.70
1.6
1.4
—
—
—
0
0
14
93
1.52
0.70
1.9
1.9
—
—
—
0
0
479
4918
0.86
0.69
5.6
5.0
1.39
1.47
mmol/l
4.13
454
4560
7
42
1.67
0.68
1.1
1.0
—
—
—
0
0
15
103
1.47
0.65
1.7
1.6
—
—
—
0
0
19
138
1.39
0.63
1.5
1.7
—
—
—
0
0
12
79
1.53
0.63
1.4
1.4
—
—
—
0
0
34
271
1.27
0.62
1.2
1.3
—
—
—
0
0
6
105
0.57
0.62
7.5
4.2
18.00
31.62
mg/l
—
6
74
8
50
1.61
0.61
1.0
1.1
86.00
104.34
pmol/l
—
8
50
0
20
0.00
0.60
0.0
3.0
—
204.80
—
0
20
482
4935
0.88
0.60
5.8
5.2
4.41
4.61
mmol/l
4.35
460
4597
0
22
0.00
0.59
0.0
1.6
—
45.96
—
0
5
6
37
1.63
0.55
1.0
1.2
—
—
—
0
0
119
1306
0.89
0.53
3.8
4.5
20.45
21.68
%
0.48
53
617
151
1634
0.90
0.53
4.6
5.4
2.06
2.60
ug/l
0.86
138
1466
169
1576
1.10
0.47
5.7
4.0
0.00
0.01
estimate
0.78
49
551
7
49
1.43
0.46
1.7
3.0
986.71
838.78
mg
—
7
49
5
33
1.52
0.41
1.4
1.5
65.00
75.45
umol/l
—
5
33
0
18
0.00
0.40
0.0
1.0
—
42.04
—
0
18
9
68
1.33
0.37
1.9
1.7
—
—
—
0
0
84
770
1.11
0.34
1.7
1.5
—
—
—
0
0
11
83
1.33
0.32
1.5
1.7
—
—
—
0
0
7
56
1.25
0.29
1.0
1.3
—
—
—
0
0
12
151
0.79
0.28
1.1
1.1
1.57
1.54
g/l
0.12
12
151
18
149
1.21
0.28
1.4
1.3
—
—
—
0
0
464
4704
0.94
0.24
4.9
4.3
1.39
1.28
mmol/l
2.54
437
4335
37
333
1.12
0.23
2.2
2.0
—
—
—
0
0
13
157
0.82
0.22
1.1
1.1
0.94
0.90
g/l
0.17
13
157
223
2162
1.05
0.21
2.2
2.0
1.56
1.35
mmol/l
2.34
202
1802
0
10
0.00
0.21
0.0
1.5
—
—
—
0
0
69
646
1.08
0.20
5.0
4.9
32.56
32.43
%
0.04
52
418
10
81
1.24
0.19
1.2
1.1
—
13.69
—
0
25
15
174
0.86
0.18
1.6
1.9
35.20
40.16
nmol/l
0.47
15
166
31
282
1.10
0.17
1.8
2.0
—
—
—
0
0
8
73
1.10
0.15
2.5
1.7
—
—
—
0
0
17
150
1.14
0.14
1.5
1.5
—
—
—
0
0
15
131
1.15
0.14
1.3
1.3
—
—
—
0
0
498
5016
0.96
0.13
6.5
5.8
2.56
2.68
mmol/l
2.70
476
4658
5
45
1.11
0.10
1.0
1.1
—
17.67
—
0
22
20
185
1.08
0.08
1.3
1.8
—
—
—
0
0
7
66
1.06
0.08
2.1
1.3
—
—
—
0
0
8
75
1.07
0.07
1.1
1.0
—
—
—
0
0
98
958
1.03
0.07
2.9
3.2
0.65
0.79
ug/l
1.13
74
606
154
1562
0.98
0.05
4.1
3.4
0.04
0.06
estimate
0.08
45
478
52
535
0.97
0.05
2.1
2.0
—
—
—
0
0
43
443
0.97
0.04
2.0
2.4
12.61
13.22
nmol/l
0.20
38
402
11
101
1.09
0.04
2.5
2.8
6.78
8.20
pmol/l
0.43
11
101
16
151
1.06
0.03
7.4
3.0
1.50
1.55
mmol/l
0.08
16
146
58
583
0.99
0.00
2.1
2.1
—
—
—
0
0
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
7
74
0.95
0.00
3.0
2.6
1.20
1.19
mmol/l
—
7
74
0
9
0.00
-0.00
0.0
3.4
—
76.44
—
0
9
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
76
0.92
-0.00
3.0
2.6
108.57
105.26
mmol/l
—
7
76
0
6
0.00
-0.00
0.0
2.3
—
38.50
—
0
6
0
5
0.00
-0.00
0.0
1.0
—
13.72
—
0
5
0
6
0.00
-0.00
0.0
1.0
—
90.00
—
0
6
9
94
0.96
-0.00
5.3
4.4
31.98
521.14
u/ml
—
9
89
0
5
0.00
-0.00
0.0
1.6
—
6.08
—
0
5
Mortality – FinRegistry
↥Association
Association between endpoint G6_MONOPLE and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_MONOPLE | 2.189 [1.82, 2.63] | < 0.001 |
| Birth year | 0.996 [0.99, 1.0] | 0.326 |
During the follow-up period (1.1.1998 — 31.12.2019), 462 out of 1605 females with G6_MONOPLE died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| G6_MONOPLE | 2.165 [1.83, 2.56] | < 0.001 |
| Birth year | 0.986 [0.98, 1.0] | 0.003 |
During the follow-up period (1.1.1998 — 31.12.2019), 563 out of 1664 males with G6_MONOPLE died.
Mortality risk
Mortality risk for people of age
years, who have G6_MONOPLE.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.199% | 0.476% |
| 5 | 1.338% | 2.423% |
| 10 | 3.21% | 5.915% |
| 15 | 6.149% | 11.001% |
| 20 | 10.489% | 18.359% |
Relationships between endpoints
↥Index endpoint: G6_MONOPLE – Monoplegia
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data